[go: up one dir, main page]

MX2017005260A - Bifidobacterias activadas y metodos de uso de las mismas. - Google Patents

Bifidobacterias activadas y metodos de uso de las mismas.

Info

Publication number
MX2017005260A
MX2017005260A MX2017005260A MX2017005260A MX2017005260A MX 2017005260 A MX2017005260 A MX 2017005260A MX 2017005260 A MX2017005260 A MX 2017005260A MX 2017005260 A MX2017005260 A MX 2017005260A MX 2017005260 A MX2017005260 A MX 2017005260A
Authority
MX
Mexico
Prior art keywords
activated
bifidobacteries
methods
same
composition
Prior art date
Application number
MX2017005260A
Other languages
English (en)
Other versions
MX382478B (es
Inventor
Kyle David
Mills David
FREEMAN-SHARKEY Samara
Original Assignee
Evolve Biosystems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55761664&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2017005260(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Evolve Biosystems Inc filed Critical Evolve Biosystems Inc
Publication of MX2017005260A publication Critical patent/MX2017005260A/es
Publication of MX382478B publication Critical patent/MX382478B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/529—Infantis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Algunas modalidades de la invención incluyen una composición y un método para tratar la disbiosis en lactantes. La composición puede incluir una mezcla de bifidobacterias activadas y un oligosacárido complejo, en donde el oligosacárido complejo puede derivarse de una fuente humana o no humana.
MX2017005260A 2014-10-24 2015-10-23 Bifidobacterias activadas y metodos de uso de las mismas. MX382478B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462068553P 2014-10-24 2014-10-24
US201562133243P 2015-03-13 2015-03-13
PCT/US2015/057226 WO2016065324A1 (en) 2014-10-24 2015-10-23 Activated bifidobacteria and methods of use thereof

Publications (2)

Publication Number Publication Date
MX2017005260A true MX2017005260A (es) 2018-01-30
MX382478B MX382478B (es) 2025-03-13

Family

ID=55761664

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017005260A MX382478B (es) 2014-10-24 2015-10-23 Bifidobacterias activadas y metodos de uso de las mismas.

Country Status (10)

Country Link
US (2) US10716816B2 (es)
EP (1) EP3209308B1 (es)
CN (2) CN114376234A (es)
AU (3) AU2015335601A1 (es)
BR (1) BR112017008284A8 (es)
CA (1) CA2965663C (es)
DK (1) DK3209308T3 (es)
MX (1) MX382478B (es)
SG (2) SG11201703298SA (es)
WO (1) WO2016065324A1 (es)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
MX382478B (es) 2014-10-24 2025-03-13 Infinant Health Inc Bifidobacterias activadas y metodos de uso de las mismas.
CN113730442A (zh) 2014-10-31 2021-12-03 潘德勒姆治疗公司 与病症的微生物治疗和诊断有关的方法和组合物
EP3193901B1 (en) 2014-12-23 2018-04-04 4D Pharma Research Limited Pirin polypeptide and immune modulation
LT3065748T (lt) 2014-12-23 2018-03-12 4D Pharma Research Limited Bacteroides thetaiotaomicron padermė ir jos panaudojimas uždegimo sumažinimui
CN107404931A (zh) * 2015-03-05 2017-11-28 雀巢产品技术援助有限公司 用于改善婴儿或幼儿粪便稠度或频率的组合物
AU2016233529B2 (en) * 2015-03-13 2022-03-10 Evolve Biosystems, Inc. Compositions that metabolize or sequester free sugar monomers and uses thereof
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
SMT202200174T1 (it) 2015-06-15 2022-05-12 4D Pharma Res Limited Composizioni comprendenti ceppi batterici
SG10201912323VA (en) 2015-06-15 2020-02-27 4D Pharma Res Ltd Compositions comprising bacterial strains
PL3307288T3 (pl) 2015-06-15 2019-12-31 4D Pharma Research Limited Kompozycje zawierające szczepy bakteryjne
HK1254843B (zh) 2015-11-20 2020-04-17 希杰生物科技株式会社 包含细菌菌株的组合物
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
EP3520801A1 (en) 2016-03-04 2019-08-07 4D Pharma Plc Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
EP3426270A4 (en) 2016-03-11 2020-04-01 Evolve Biosystems, Inc. A TRANSITIONAL COMMENSAL MICROORGANISM TO IMPROVE INTESTINAL HEALTH
CA3029631A1 (en) 2016-07-01 2018-01-04 Evolve Biosystems, Inc. Method for facilitating maturation of the mammalian immune system
TWI802545B (zh) 2016-07-13 2023-05-21 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
JP7212945B2 (ja) 2017-05-22 2023-01-26 フォーディー ファーマ リサーチ リミテッド 細菌株を含む組成物
EP3630942B1 (en) 2017-05-24 2022-11-30 4D Pharma Research Limited Compositions comprising bacterial strain
MA49425A (fr) 2017-06-14 2020-04-22 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA49373B1 (fr) 2017-06-14 2021-02-26 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
TWI767013B (zh) 2017-06-14 2022-06-11 英商4D製藥研究有限公司 包含細菌品系之組成物
WO2019008104A1 (en) * 2017-07-07 2019-01-10 Nestec S.A. FORTIFYING HUMAN MILK
CN107365705B (zh) * 2017-07-14 2021-01-12 江苏微康生物科技有限公司 一种油溶性益生菌冻干菌粉的冻干保护剂及其应用
CN111372596A (zh) 2017-08-30 2020-07-03 潘德勒姆治疗公司 用于治疗微生物组相关病症的方法和组合物
WO2019055718A1 (en) * 2017-09-13 2019-03-21 Evolve Biosystems, Inc. METABOLOMIC REVISION OF MAMMALIAN INFANTS
US20200345055A1 (en) 2018-01-17 2020-11-05 Evolve Biosystems, Inc. Activation of conditionally-expressed oligosaccharide pathways during fermentation of probiotic strains
SG11202011820VA (en) 2018-05-30 2020-12-30 Evolve Biosystems Inc Compostions and method of use for h5 competent bifidobacterium longum subsp. infantis
WO2019232513A1 (en) * 2018-06-01 2019-12-05 Evolve Biosystems, Inc. Compositions and methods to promote host defense and stimulate, expand, and/or reset t cell repertoires
US20210161924A1 (en) * 2018-06-19 2021-06-03 Evolve Biosystems, Inc. Novel oligosaccharides for use in prebiotic applications
AU2019306649A1 (en) 2018-07-19 2021-02-04 Pendulum Therapeutics, Inc. Methods and compositions for microbial engraftment
EP3927171A4 (en) 2019-02-22 2022-11-30 Aquero Canada Ltd. ENRICHED MILK COMPOSITIONS AND METHODS FOR PREPARING THEM
KR20220155595A (ko) * 2020-03-20 2022-11-23 글리콤 에이/에스 고체 hmo 생성물을 제공하는 방법, 및 이에 의해 수득된 고체 hmo 생성물
CN111826324A (zh) * 2020-08-05 2020-10-27 厦门惠盈动物科技有限公司 一种鼠李糖乳杆菌菌粉的制备方法
CN116322371A (zh) * 2020-08-14 2023-06-23 普罗莱克塔生物科学公司 与细菌疗法一起使用的人乳寡糖组合物
CN114568516A (zh) * 2020-11-30 2022-06-03 内蒙古伊利实业集团股份有限公司 包含长双歧杆菌婴儿亚种与母乳低聚糖的组合物及其应用
CN114568520A (zh) * 2020-11-30 2022-06-03 内蒙古伊利实业集团股份有限公司 包含长双歧杆菌婴儿亚种的婴幼儿配方粉及其应用
US20240016195A1 (en) 2020-12-11 2024-01-18 Dsm Ip Assets B.V. Improved prebiotic formulations
IT202100024911A1 (it) * 2021-09-29 2023-03-29 Univ Degli Studi Di Napoli Federico Ii Dipartimento Di Fisica Ettore Pancini Prebiotico a base di "scotta" delattosata per la prevenzione e gestione della disbiosi intestinale
CN116407484B (zh) * 2021-12-29 2025-08-26 嘉必优生物技术（武汉）股份有限公司 一种修护皮肤屏障的护肤组合物及其应用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716615A (en) 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
RU2180915C1 (ru) 2001-04-28 2002-03-27 Московский научно-исследовательский институт эпидемиологии и микробиологии им. Г.Н. Габричевского Консорциум бифидобактерий и лактобацилл, используемый для приготовления бактериальных препаратов, заквасок для кисломолочных продуктов, ферментированных и неферментированных пищевых продуктов, биологически активных добавок, предназначенных для коррекции микрофлоры детей в возрасте до 3-х лет
DE602004017885D1 (de) * 2003-10-24 2009-01-02 Nutricia Nv Symbiotische zusammensetzung für kleinkinder
US20070082087A1 (en) * 2005-10-06 2007-04-12 Schweitzer Biotech Company Ltd. Fermented milk products containing bifidobacterium longum and isomalto oligosaccharide and the process for producing the same
EP1776877A1 (en) 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
WO2007140622A1 (en) 2006-06-09 2007-12-13 Nutravital Inc. Dairy-derived probiotic compositions and uses thereof
EP2069520A4 (en) * 2006-09-15 2010-05-05 Univ California GENESQUES FROM BIFIDOBACTERIA AND THEIR USE
US8197872B2 (en) 2007-05-17 2012-06-12 The Regents Of The University Of California Human milk oligosaccharides to promote growth of beneficial gut bacteria
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
EP2072052A1 (en) 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
UA32462U (uk) 2008-02-14 2008-05-12 Харьковский Национальный Медицинский Университет Спосіб оцінки ефективності корекції порушень мікробіоценозу кишечнику у дітей молодшого віку з атопічним дерматитом
CA2658440C (en) * 2008-04-04 2016-08-23 Kraft Foods Global Brands Llc Dairy composition with probiotics and anti-microbial system
EP2143341A1 (en) * 2008-07-08 2010-01-13 Nestec S.A. Nutritional Composition Containing Oligosaccharide Mixture
CA2725051A1 (en) 2008-05-27 2009-12-03 Nestec S.A. Probiotics to improve gut microbiota
MX349705B (es) * 2008-11-11 2017-08-09 Alimentary Health Ltd Bifidobacterium longum.
CN102300575A (zh) 2008-12-02 2011-12-28 普罗莱克塔生物科学公司 人乳渗透物组合物及其制备和使用方法
US9649380B2 (en) 2009-01-12 2017-05-16 Pfizer Italia S.R.L. Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin
US8198872B2 (en) 2009-03-10 2012-06-12 Honeywell International, Inc. Starter-generator with improved excitation
US7888062B1 (en) * 2010-02-01 2011-02-15 Microbios, Inc. Process and composition for the manufacture of a microbial-based product
RU2012140011A (ru) 2010-02-19 2014-03-27 Глюком А/С Получение 6'-о-сиалиллактозы и промежуточные соединения
ES2680920T3 (es) 2010-07-12 2018-09-11 The Regents Of The University Of California Oligosacáridos de leche bovina
EP2465509A1 (en) 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating acute respiratory tract infections
EP2465507A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating skin diseases
EP2454948A1 (en) * 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
CN103763940B (zh) 2010-12-31 2015-10-14 雅培制药有限公司 促进有益微生物群生长的益生菌和人乳寡糖的合益素组合
MX345413B (es) * 2011-02-10 2017-01-27 Nestec Sa Modulacion del crecimiento de bifidobacterias mediante el uso de una combinacion de oligosacaridos que se encuentran en la leche humana.
US9579353B2 (en) 2011-06-10 2017-02-28 Prothera, Inc. Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
IN2014DN07601A (es) * 2012-02-14 2015-05-15 Univ California
US10165788B2 (en) 2013-06-17 2019-01-01 The Regents Of The University Of California Methods and compositions for improved digestion of milk oligosaccharides
MX382478B (es) 2014-10-24 2025-03-13 Infinant Health Inc Bifidobacterias activadas y metodos de uso de las mismas.
US10350249B2 (en) 2014-12-12 2019-07-16 The Regents Of The University Of California Reduction of milk glycans and their degradation products in the neonate gut

Also Published As

Publication number Publication date
NZ731722A (en) 2024-11-29
CN114376234A (zh) 2022-04-22
CA2965663C (en) 2023-04-04
EP3209308A1 (en) 2017-08-30
US10716816B2 (en) 2020-07-21
SG10202002593SA (en) 2020-05-28
WO2016065324A1 (en) 2016-04-28
AU2024264651A1 (en) 2025-03-13
BR112017008284A2 (pt) 2017-12-19
AU2015335601A1 (en) 2017-06-01
DK3209308T3 (da) 2022-10-03
SG11201703298SA (en) 2017-05-30
US20170304375A1 (en) 2017-10-26
MX382478B (es) 2025-03-13
EP3209308B1 (en) 2022-08-03
BR112017008284A8 (pt) 2023-04-11
AU2021204822A1 (en) 2021-08-05
CA2965663A1 (en) 2016-04-28
US20200397837A1 (en) 2020-12-24
EP3209308A4 (en) 2018-06-27
CN107249611A (zh) 2017-10-13

Similar Documents

Publication Publication Date Title
MX2017005260A (es) Bifidobacterias activadas y metodos de uso de las mismas.
CO2017005784A2 (es) Compuestos bicíclicos fusionados para el tratamiento de enfermedades
NZ720769A (en) Anti-siglec-8 antibodies and methods of use thereof
EP4193993A3 (en) Combinations of cannabinoids and n-acylethanolamines
CO2017007121A2 (es) Compuestos bicíclicos fusionados para el tratamiento de enfermedades
EA201790787A1 (ru) Снижение вязкости фармацевтических составов
MX2017009720A (es) Composiciones de oligosacaridos para el uso en composiciones nutricionales y metodos para producirlas.
SI3481846T1 (sl) 11-substituirani 24-hidroksisteroli za uporabo pri zdravljenju stanj, povezanih z NMDA
HK1217490A1 (zh) 黃斑變性治療中的新穎捕獲劑
SG10202106240SA (en) Methods and compositions for determining, and for minimizing, the likelihood of development of allergy in infants
EP3130620A4 (en) Silicone composition, silicone emulsion composition, and fiber treatment agent
MX374385B (es) Apilimod para uso en el tratamiento de melanoma.
FR3029915B1 (fr) Tripeptides, compositions les comprenant et utilisations notamment cosmetiques
CL2016002151A1 (es) Derivados de piridazina para uso en la prevención o el tratamiento de un trastorno atáxico
MX2017007000A (es) Composiciones que comprenden acido 15-hidroxieicosapentaenoico (15-hepe) y metodos para tratar o prevenir la fibrosis usando las mismas.
MX2018005987A (es) Compuestos heterociclicos para el tratamiento de enfermedades.
ZA201706254B (en) Oil blends, processes for the preparation thereof and their use in formulas
PH12016501434A1 (en) Compositions for use in the treatment of allergic conditions
ZA201807136B (en) Compositions for use in treating tendon degeneration
BR112017013928A2 (pt) composição alimentar e método de uso.
MX2017008612A (es) Películas envolventes con opacidad aumentada.
EP3139744A4 (en) Methods and compositions for treating and preventing tinnitus
MX375355B (es) Una variante del factor xa para usarse en el tratamiento de la hemorragia cerebral.
SG11201609762TA (en) Anti-allergic agent, agent for improving allergic diarrhea and pharmaceutical composition
TH1601002624A (th) องค์ประกอบสำหรับใช้ในการป้องกันหรือรักษาการติดเชื้อ urt ในทารกหรือเด็ก เล็กที่มีความเสี่ยง